Bryan, Garnier & Co's News

Actelion: Delivering well on schedule

BUY-Top Picks, Fair Value CHF156 vs. CHF154 (+20%)
News published on
October Wednesday 21, 2015


A new FV of CHF156 derives from revised assumptions with Opsumit as it should take fewer years than we anticipated to reach peak sales. The investment case is very much valid post Q3 numbers.


For more information, please contact marketing@bryangarnier.com